187 related articles for article (PubMed ID: 34152087)
21. Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?
Fernandes GS; Marques DF; Girardi DM; Braghiroli MIF; Coudry RA; Meireles SI; Katz A; Hoff PM
Clinics (Sao Paulo); 2017 Oct; 72(10):588-594. PubMed ID: 29160420
[TBL] [Abstract][Full Text] [Related]
22. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A
Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272
[TBL] [Abstract][Full Text] [Related]
23. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.
Bombard Y
Genome; 2015 Dec; 58(12):491-7. PubMed ID: 26577841
[No Abstract] [Full Text] [Related]
24. Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer.
Lobo JM; Trifiletti DM; Sturz VN; Dicker AP; Buerki C; Davicioni E; Cooperberg MR; Karnes RJ; Jenkins RB; Den RB; Showalter TN
Clin Genitourin Cancer; 2017 Jun; 15(3):e299-e309. PubMed ID: 28089723
[TBL] [Abstract][Full Text] [Related]
25. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
26. Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bond.
Ginsburg GS; Kuderer NM
J Clin Oncol; 2012 Dec; 30(34):4233-42. PubMed ID: 23071236
[TBL] [Abstract][Full Text] [Related]
27. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
Damodaran S; Berger MF; Roychowdhury S
Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
[TBL] [Abstract][Full Text] [Related]
28. Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.
Tsongalis GJ; Coleman WB
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S60-S66. PubMed ID: 28921651
[TBL] [Abstract][Full Text] [Related]
29. Better Outcomes with Precision Medicine.
Cancer Discov; 2016 Dec; 6(12):1296-1297. PubMed ID: 27784709
[TBL] [Abstract][Full Text] [Related]
30. Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort.
Swanson KM; Zhu Y; Rojas RL; St Sauver JL; Bielinski SJ; Jacobsen DJ; Visscher SL; Wang L; Weinshilboum R; Borah BJ
PLoS One; 2020; 15(5):e0233316. PubMed ID: 32428022
[TBL] [Abstract][Full Text] [Related]
31. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
32. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
33. An integrated clinical and genomic information system for cancer precision medicine.
Jang Y; Choi T; Kim J; Park J; Seo J; Kim S; Kwon Y; Lee S; Lee S
BMC Med Genomics; 2018 Apr; 11(Suppl 2):34. PubMed ID: 29697362
[TBL] [Abstract][Full Text] [Related]
34. The opportunities and challenges of implementing genomics-informed personalized medicine.
Chisholm RL
Clin Pharmacol Ther; 2013 Aug; 94(2):181-2. PubMed ID: 23872829
[No Abstract] [Full Text] [Related]
35. Estimating the costs of genomic sequencing in cancer control.
Gordon LG; White NM; Elliott TM; Nones K; Beckhouse AG; Rodriguez-Acevedo AJ; Webb PM; Lee XJ; Graves N; Schofield DJ
BMC Health Serv Res; 2020 Jun; 20(1):492. PubMed ID: 32493298
[TBL] [Abstract][Full Text] [Related]
36. Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine.
Tsimberidou AM; Hong DS; Wheler JJ; Falchook GS; Janku F; Naing A; Fu S; Piha-Paul S; Cartwright C; Broaddus RR; Nogueras Gonzalez GM; Hwu P; Kurzrock R
J Hematol Oncol; 2019 Dec; 12(1):145. PubMed ID: 31888672
[TBL] [Abstract][Full Text] [Related]
37. Using clinical genomic sequencing to guide personalized cancer therapy in China.
Bai Y; Wang G; Wei J; Dai C; Xu X; Cai X; Wu B; Sun W; Xu Q; Jiao S
Per Med; 2019 Jul; 16(4):287-299. PubMed ID: 30895868
[No Abstract] [Full Text] [Related]
38. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
[TBL] [Abstract][Full Text] [Related]
39. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
Mack SC; Northcott PA
J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
[TBL] [Abstract][Full Text] [Related]
40. Copenhagen Prospective Personalized Oncology (CoPPO)-Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials.
Tuxen IV; Rohrberg KS; Oestrup O; Ahlborn LB; Schmidt AY; Spanggaard I; Hasselby JP; Santoni-Rugiu E; Yde CW; Mau-Sørensen M; Nielsen FC; Lassen U
Clin Cancer Res; 2019 Feb; 25(4):1239-1247. PubMed ID: 30274980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
